Regulonix Holding jobs and careers

About Regulonix Holding

Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically validated pain target – and focusing on the signaling pathways that control this channel’s activity, the Regulonix team has isolated compounds demonstrated in animal models to be non-addictive and more effective than morphine.

Founded in 2018 by May Khanna, Michael Sember, Rajesh Khanna and Vijay Gokhale.